Partners Sas Sofinnova - Net Worth and Insider Trading
Partners Sas Sofinnova Net Worth
The estimated net worth of Partners Sas Sofinnova is at least $123 Million dollars as of 2024-05-16. Partners Sas Sofinnova is the 10% Owner of CinCor Pharma Inc and owns about 4,220,979 shares of CinCor Pharma Inc (CINC) stock worth over $123 Million. Details can be seen in Partners Sas Sofinnova's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Partners Sas Sofinnova has not made any transactions after 2022-08-15 and currently still holds the listed stock(s).
Transaction Summary of Partners Sas Sofinnova
Partners Sas Sofinnova Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Partners Sas Sofinnova owns 4 companies in total, including HOOKIPA Pharma Inc (HOOK) , Flexion Therapeutics Inc (FLXN) , and BioAmber Inc (BIOA.U) among others .
Click here to see the complete history of Partners Sas Sofinnova’s form 4 insider trades.
Insider Ownership Summary of Partners Sas Sofinnova
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HOOK | HOOKIPA Pharma Inc | 2019-04-17 | 10 percent owner |
| FLXN | Flexion Therapeutics Inc | 2014-10-29 | 10 percent owner |
| BIOA.U | BioAmber Inc | 2013-05-14 | 10 percent owner |
 | | 2022-08-15 | 10 percent owner |
Partners Sas Sofinnova Latest Holdings Summary
Partners Sas Sofinnova currently owns a total of 1 stock. Partners Sas Sofinnova owns 4,220,979 shares of CinCor Pharma Inc (CINC) as of August 15, 2022, with a value of $123 Million.
Latest Holdings of Partners Sas Sofinnova
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CINC | CinCor Pharma Inc | 2022-08-15 | 4,220,979 | 29.06 | 122,661,650 |
Holding Weightings of Partners Sas Sofinnova
Partners Sas Sofinnova Form 4 Trading Tracker
According to the SEC Form 4 filings, Partners Sas Sofinnova has made a total of 2 transactions in CinCor Pharma Inc (CINC) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in CinCor Pharma Inc is the acquisition of 133,333 shares on August 15, 2022, which cost Partners Sas Sofinnova around $4 Million.
Insider Trading History of Partners Sas Sofinnova
- 1
Partners Sas Sofinnova Trading Performance
GuruFocus tracks the stock performance after each of Partners Sas Sofinnova's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Partners Sas Sofinnova is -1.19%. GuruFocus also compares Partners Sas Sofinnova's trading performance to market benchmark return within the same time period. The performance of stocks bought by Partners Sas Sofinnova within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Partners Sas Sofinnova's insider trading performs compared to the benchmark.
Performance of Partners Sas Sofinnova
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 15.95 | | | | | |
| Relative Return to S&P 500(%) | 23.68 | | | | | |
Partners Sas Sofinnova Ownership Network
Partners Sas Sofinnova Owned Company Details
What does HOOKIPA Pharma Inc do?
Who are the key executives at HOOKIPA Pharma Inc?
Partners Sas Sofinnova is the 10 percent owner of HOOKIPA Pharma Inc. Other key executives at HOOKIPA Pharma Inc include director & Chief Financial Officer Reinhard Kandera , director & Chief Executive Officer Jorn Aldag , and Chief Medical Officer Katia Schlienger .
HOOKIPA Pharma Inc (HOOK) Insider Trades Summary
Over the past 18 months, Partners Sas Sofinnova made no insider transaction in HOOKIPA Pharma Inc (HOOK). Other recent insider transactions involving HOOKIPA Pharma Inc (HOOK) include a net purchase of 27,000 shares made by Reinhard Kandera , and a net purchase of 20,000 shares made by Jorn Aldag .
In summary, during the past 3 months, insiders sold 0 shares of HOOKIPA Pharma Inc (HOOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of HOOKIPA Pharma Inc (HOOK) were sold and 47,000 shares were bought by its insiders, resulting in a net purchase of 47,000 shares.
HOOKIPA Pharma Inc (HOOK)'s detailed insider trading history can be found in Insider Trading Tracker table.
HOOKIPA Pharma Inc Insider Transactions
Partners Sas Sofinnova Mailing Address
Above is the net worth, insider trading, and ownership report for Partners Sas Sofinnova. You might contact Partners Sas Sofinnova via mailing address: 17 Rue De Serene, Paris I0 75008.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
